Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial - PubMed (original) (raw)

Clinical Trial

Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial

L Diggle et al. BMJ. 2000.

Abstract

Objective: To compare rates of local reactions associated with two needle sizes used to administer routine immunisations to infants.

Design: Randomised controlled trial.

Setting: Routine immunisation clinics in eight general practices in Buckinghamshire.

Participants: Healthy infants attending for third primary immunisation due at 16 weeks of age: 119 infants were recruited, and 110 diary cards were analysed.

Interventions: Immunisation with 25 gauge, 16 mm, orange hub needle or 23 gauge, 25 mm, blue hub needle.

Main outcome measures: Parental recordings of redness, swelling, and tenderness for three days after immunisation.

Results: Rate of redness with the longer needle was initially two thirds the rate with the smaller needle (relative risk 0.66 (95% confidence interval 0.45 to 0.99), P=0.04), and by the third day this had decreased to a seventh (relative risk 0.13 (0.03 to 0.56), P=0.0006). Rate of swelling with the longer needle was initially about a third that with the smaller needle (relative risk 0.39 (0.23 to 0.67), P=0.0002), and this difference remained for all three days. Rates of tenderness were also lower with the longer needle throughout follow up, but not significantly (relative risk 0.60 (0.29 to 1.25), P=0.17).

Conclusions: Use of 25 mm needles significantly reduced rates of local reaction to routine infant immunisation. On average, for every five infants vaccinated, use of the longer needle instead of the shorter needle would prevent one infant from experiencing any local reaction. Vaccine manufacturers should review their policy of supplying the shorter needle in vaccine packs.

PubMed Disclaimer

Figures

Figure

Flow chart describing randomisation sequence

Comment in

ACP J Club. 2001 Jul-Aug;135(1):29
Needle length and incidence of local reactions to immunisation. Is there a real benefit for the child?
Heininger U. Heininger U. BMJ. 2001 Feb 24;322(7284):492-3. BMJ. 2001. PMID: 11222435 No abstract available.
Needle length and incidence of local reactions to immunisation. How quickly can research change practice?
Platt J. Platt J. BMJ. 2001 Feb 24;322(7284):492. BMJ. 2001. PMID: 11222440 Free PMC article. No abstract available.

Cited by

Vaccine related reactogenicity for primary immunization: a randomized controlled trial of 23(wider) vs. 25(narrower) gauge needles with same lengths.
Bharti B, Grewal A, Kalia R, Pathak P. Bharti B, et al. Indian J Pediatr. 2010 Nov;77(11):1241-6. doi: 10.1007/s12098-010-0173-3. Epub 2010 Sep 7. Indian J Pediatr. 2010. PMID: 20821281 Clinical Trial.
Effect of vaccine administration modality on immunogenicity and efficacy.
Zhang L, Wang W, Wang S. Zhang L, et al. Expert Rev Vaccines. 2015;14(11):1509-23. doi: 10.1586/14760584.2015.1081067. Epub 2015 Aug 27. Expert Rev Vaccines. 2015. PMID: 26313239 Free PMC article. Review.
Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial.
Diggle L, Deeks JJ, Pollard AJ. Diggle L, et al. BMJ. 2006 Sep 16;333(7568):571. doi: 10.1136/bmj.38906.704549.7C. Epub 2006 Aug 4. BMJ. 2006. PMID: 16891328 Free PMC article. Clinical Trial.
Protection Induced by Vaccination with Recombinant Baculovirus and Virus-like Particles Expressing Toxoplasma gondii Rhoptry Protein 18.
Yoon KW, Chu KB, Kang HJ, Kim MJ, Eom GD, Mao J, Lee SH, Ahmed MA, Quan FS. Yoon KW, et al. Vaccines (Basel). 2022 Sep 22;10(10):1588. doi: 10.3390/vaccines10101588. Vaccines (Basel). 2022. PMID: 36298453 Free PMC article.
Needle size for vaccination procedures in children and adolescents.
Beirne PV, Hennessy S, Cadogan SL, Shiely F, Fitzgerald T, MacLeod F. Beirne PV, et al. Cochrane Database Syst Rev. 2018 Aug 9;8(8):CD010720. doi: 10.1002/14651858.CD010720.pub3. Cochrane Database Syst Rev. 2018. PMID: 30091147 Free PMC article.

References

1. Department of Health. Immunisation against infectious diseases. London: HMSO; 1996.
1. World Health Organisation. Immunisation in practice. Module 8. During a session: giving immunisations. Geneva: WHO; 1998. www.who.int/vaccines-documents/DoxTrng/H4IIP.htm . ( www.who.int/vaccines-documents/DoxTrng/H4IIP.htm (accessed 3 October 2000).) (accessed 3 October 2000).)
1. Department of Health. Current vaccine issues: action update. London: DoH; 1999. . (Professional letter PL/CMO/99/5.)
1. Diggle L. London: Royal College of Nursing Institute; 1999. A randomised controlled trial of different needle lengths on the incidence of local reactions when administering the combined injection of diphtheria/pertussis/tetanus (DPT) and Haemophilus influenzae type b (Hib) to infants at 4-months of age [dissertation]
1. Mark A, Carlsson R, Granstrom M. Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents. Vaccine. 1999;17:2067–2072. - PubMed

Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial - PubMed (original) (raw)